Sanford Svai's most recent trade in Rani Therapeutics Holdings Inc - Ordinary Shares Class A was a trade of 325,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 23, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Rani Therapeutics Holdings... | Svai Sanford | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2025 | 325,000 | 325,000 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Svai Sanford | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Mar 2024 | 323,500 | 323,500 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Sanford Svai | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 171,500 | 34,300 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Sanford Svai | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 171,500 | 171,500 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Svai Sanford | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 83,724 | 127,788 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Svai Sanford | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 83,724 | 83,724 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Sanford Svai | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2023 | 58,334 | 58,334 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Svai Sanford | Chief Financial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 16 Dec 2023 | 58,334 | 41,666 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Svai Sanford | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 205,800 | 205,800 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Svai Sanford | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 139,000 | 258,597 | - | 0 | Class A Common Stock | |
Rani Therapeutics Holdings... | Svai Sanford | CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.95 per share. | 22 Mar 2023 | 3,355 | 119,597 | - | 5.9 | 19,962 | Class A Common Stock |
Rani Therapeutics Holdings... | Svai Sanford | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.89 per share. | 09 Sep 2022 | 18,362 | 120,738 | - | 9.9 | 181,600 | Class A Common Stock |
Rani Therapeutics Holdings... | Svai Sanford | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
Rani Therapeutics Holdings... | Svai Sanford | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Mar 2022 | 32,900 | 139,100 | - | 0 | Class A Common Stock | |
Rani Therapeutics Holdings... | Svai Sanford | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Sep 2021 | 106,200 | 106,200 | - | 0 | Class A Common Stock |